(+)-Majoranolide analogues from regioselective Baeyer–Villiger reactions mediated by hypervalent iodine(iii) reagents

Title
(+)-Majoranolide analogues from regioselective Baeyer–Villiger reactions mediated by hypervalent iodine(iii) reagents
Publication Date
2026-08-05
Author(s)
Lamb, Oscar J
Podversnik, Harald
Burns, Amy
Ghahri, Maryam
Shah, Rohan
Gulati, Vandana
( author )
OrcID: https://orcid.org/0000-0001-6314-4130
Email: vgulati@une.edu.au
UNE Id une-id:vgulati
Greatrex, Ben W
( author )
OrcID: https://orcid.org/0000-0002-0356-4966
Email: bgreatre@une.edu.au
UNE Id une-id:bgreatre
Type of document
Journal Article
Language
en
Entity Type
Publication
Publisher
Royal Society of Chemistry
Place of publication
United Kingdom
DOI
10.1039/d6ob00870d
UNE publication id
une:1959.11/75046
Abstract

A series of enantiopure (+)-majoranolide analogues has been synthesized from the cellulose-derived chiral platform chemical (−)-Cyrene. The bicyclic ketone was substituted at C3 with a variety of benzylidene moieties via base-catalysed aldol condensations and a subsequent Baeyer–Villiger oxidation was achieved using the hypervalent iodine(iii) reagent (diacetoxyiodo)benzene (PIDA) in combination with methanesulfonic acid. The reaction proceeded via an intermediate hemiketal, with rate and yield enhancement using solvent mixtures containing 2,2,2-trifluoroethanol. PIDA gave higher yields than peroxyacid mediated reactions due to improved selectivity in the migratory insertion. (+)-Majoranolide analogues had good anticancer activity with IC50 values as low as 6.0 µg mL−1 against A-549 lung carcinoma cells and 6.3 µg mL−1 against HeLa cervical carcinoma cells. Only the natural product (+)-majoranolide B exhibited significant antimicrobial activity, limited to S. aureus (MIC = 3.1 µg mL−1). Several compounds displayed anti-quorum sensing activity exceeding 80% inhibition, with the alkylidene ketone precursors similar to the benzylidene lactones.

Link
Citation
Organic and biomolecular chemistry, 24(30), p. 6198-6204
ISSN
1477-0539
1477-0520
Pubmed ID
42478792
Start page
6198
End page
6204

Files:

NameSizeformatDescriptionLink